![]() Nouscom Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
| ![]() Repair Biotechnologies Repair Biotechnologies is developing therapies with the goals of reversing atherosclerosis and atrophy of the thymus. | |||
Founding Date | Founding Date 2015 | Founding Date 2017 | Founding Date 2018 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Basel, CH HQ Roma, IT | Locations Alachua, US HQ Alachua, US | Locations Syracuse, US HQ | Locations Waltham, US HQ |
Employees | Employees 633% increase | Employees 13 | Employees 9 | Employees 613% decrease |
Funding | ||||
Latest funding round | Latest funding round $ 49m (over 7 years ago) | Latest funding round $ 30m (almost 7 years ago) | Latest funding round $ 2.2m (about 6 years ago) | Latest funding round $ 60m (over 5 years ago) |
Total funding raised | Total funding raised $ 62.6m | Total funding raised $ 30m | Total funding raised $ 2.2m | Total funding raised $ 60m |
Lacerta Therapeutics is a clinical stage gene therapy company.
View companyRepair Biotechnologies is developing therapies with the goals of reversing atherosclerosis and atrophy of the thymus.
View companyAffinia Therapeutics is a biotech company.
View company